🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 5 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/06/2000 | 42,63 | 42,63 | 41,75 | 42,25 | -0,59% | 2,05% | 372.600 |
| 21/06/2000 | 40,50 | 43,00 | 39,81 | 42,50 | +6,90% | 7,87% | 772.800 |
| 20/06/2000 | 44,06 | 44,81 | 37,00 | 39,76 | -9,77% | 17,73% | 3.223.200 |
| 19/06/2000 | 44,00 | 45,63 | 43,75 | 44,06 | +0,09% | 4,26% | 547.400 |
| 16/06/2000 | 43,00 | 44,44 | 43,00 | 44,02 | +1,94% | 3,34% | 260.200 |
| 15/06/2000 | 43,75 | 44,00 | 42,75 | 43,19 | +0,22% | 2,86% | 328.400 |
| 14/06/2000 | 43,00 | 43,75 | 42,50 | 43,09 | +0,44% | 2,91% | 313.000 |
| 13/06/2000 | 42,50 | 43,47 | 42,19 | 42,91 | -1,72% | 3,01% | 553.600 |
| 12/06/2000 | 39,50 | 45,06 | 39,50 | 43,66 | +7,54% | 14,08% | 385.200 |
| 09/06/2000 | 38,50 | 41,09 | 37,63 | 40,59 | +6,13% | 9,01% | 401.000 |
| 08/06/2000 | 39,88 | 40,13 | 37,50 | 38,25 | -3,62% | 6,58% | 389.000 |
| 07/06/2000 | 36,00 | 41,50 | 36,00 | 39,69 | +8,83% | 15,28% | 788.800 |
| 06/06/2000 | 34,50 | 36,50 | 33,56 | 36,47 | +6,48% | 8,51% | 548.600 |
| 05/06/2000 | 32,47 | 35,00 | 31,88 | 34,25 | +2,53% | 9,62% | 182.200 |
| 02/06/2000 | 32,75 | 33,63 | 32,56 | 33,41 | +2,20% | 3,24% | 379.200 |
| 01/06/2000 | 32,13 | 32,88 | 32,13 | 32,69 | +2,15% | 2,33% | 146.400 |
| 31/05/2000 | 32,06 | 32,50 | 31,53 | 32,00 | +0,20% | 3,02% | 190.000 |
| 30/05/2000 | 31,25 | 31,94 | 30,81 | 31,94 | +2,61% | 3,60% | 340.800 |
| 26/05/2000 | 32,00 | 32,13 | 30,75 | 31,13 | -3,11% | 4,30% | 217.800 |
| 25/05/2000 | 31,81 | 33,00 | 31,38 | 32,13 | +1,98% | 5,11% | 811.000 |
| 24/05/2000 | 30,06 | 32,00 | 30,06 | 31,50 | +3,38% | 6,44% | 558.800 |
| 23/05/2000 | 30,50 | 31,06 | 30,13 | 30,47 | +1,14% | 3,07% | 532.400 |
| 22/05/2000 | 31,75 | 31,75 | 30,03 | 30,13 | -1,73% | 5,41% | 440.600 |
| 19/05/2000 | 30,50 | 32,00 | 30,00 | 30,66 | -1,31% | 6,56% | 386.400 |
| 18/05/2000 | 31,00 | 31,19 | 30,56 | 31,06 | -2,36% | 2,02% | 516.200 |
| 17/05/2000 | 30,78 | 32,50 | 30,78 | 31,81 | +1,39% | 5,58% | 112.000 |
| 16/05/2000 | 31,13 | 32,75 | 30,81 | 31,38 | +3,72% | 6,22% | 161.000 |
| 15/05/2000 | 31,00 | 32,00 | 29,50 | 30,25 | -5,47% | 8,06% | 233.400 |
| 12/05/2000 | 32,56 | 32,66 | 31,75 | 32,00 | -1,44% | 2,78% | 169.800 |
| 11/05/2000 | 33,44 | 33,47 | 32,38 | 32,47 | -2,26% | 3,27% | 225.600 |